Evaluation of an epitope-blocking enzyme-linked immunosorbent assay for the diagnosis of west nile virus infections in humans

Clinical and Vaccine Immunology

Volumn 16, Issue 5, 2009, Pages 749-755

  Lorono Pino M A ^a,b   Farfan Ale, J A ^b   Blitvich, B J ^a,e   Beebe, J L ^c,f   Jarman, R G ^d   Beaty, B J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^c Colorado Department of Public Health and Environment ^*  (United States)

^d U S ARMY   (United States)

^e IOWA STATE UNIVERSITY   (United States)

^f San Luis Obispo County Health Agency   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3.1112G; MONOCLONAL ANTIBODY 6B6C 1; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; JAPANESE ENCEPHALITIS VIRUS; MAJOR CLINICAL STUDY; MEXICO; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THAILAND; UNITED STATES; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; PLAQUE ASSAY; SENSITIVITY AND SPECIFICITY; WEST NILE FEVER; YOUNG ADULT;

EID: 66849126217     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00393-08     Document Type: Article

References (42)

1. Anantapreecha, S., S. Chanama, A. A.-Nuegoonpipat, S. Naemkhunthot, A. Sa-Ngasang, P. Sawanpanyalert, and I. Kurane. 2005. Serological and viro- logical features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002. Epidemiol. Infect. 133:503-507.
2. Beaty, B. J., C. H. Calisher, and R. E. Shope (ed.). 1989. Arboviruses, p. 797-855. In N. J. Schmidt and R. W. Emmons (ed.), Diagnostic procedures for viral, rickettsial, and chlamydial infections, 6th ed. American Public Health Association, Washington, DC.
3. Blitvich, B. J., R. A. Bowen, N. L. Marlenee, R. A. Hall, M. L. Bunning, and B. J. Beaty. 2003. Epitope-blocking enzyme-linked immunosorbent assays for detection of West Nile virus antibodies in domestic mammals. J. Clin. Microbiol. 41:2676-2679.
4. Blitvich, B. J., N. L. Marlenee, R. A. Hall, C. H. Calisher, R. A. Bowen, J. T. Roehrig, N. Komar, S. A. Langevin, and B. J. Beaty. 2003. Epitope-blocking enzyme-linked immunosorbent assays for the detection of serum antibodies to West Nile virus in multiple avian species. J. Clin. Microbiol. 41:1041-1047.
5. Bond, J. O. 1969. St. Louis encephalitis and dengue fever in the Caribbean area: evidence of possible cross-protection. Bull. W. H. O. 40:160-163.
6. Colorado Department of Public Health and Environment. 2003. Human West Nile virus infections: Colorado, 2003. Colorado Department of Public Health and Environment, Disease Control and Environmental Epidemiology Division. http://www.cdphe.state.co.us/dc/zoonosis/wnv/wnvpast.html
7. Dauphin, G., S. Zientara, H. Zeller, and B. Murgue. 2004. West Nile:worldwide current situation in animals and humans. Comp. Immunol. Microbiol. Infect. Dis. 27:343-355.
8. Diaz, F. J., W. C. Black IV, J. A. Farfan-Ale, M. A. Loroiio-Pino, K. E. Olson, and B. J. Beaty. 2006. Dengue virus circulation and evolution in Mexico: a phylogenetic perspective. Arch. Med. Res. 37:760-773.
9. Endy, T. P., A. Nisalak, S. Chunsuttitwat, D. W. Vaughn, S. Green, F. A. Ennis, A. L. Rothman, and D. H. Library. 2004. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J. Infect. Dis. 189:990-1000.
10. Farfan-Ale, J. A., B. J. Blitvich, M. A. Loronio-Pino, N. L. Marlenee, E. P.Rosado-Paredes, J. E. Garcia-Rejon, L. F. Flores-Flores, L. Chulim-Perera, M. Lopez-Uribe, G. Perez-Mendoza, I. Sanchez-Herrera, W. Santamaria, J.Moo-Huchim, D. J. Gubler, B. C. Cropp, C. H. Calisher, and B. J. Beaty.2004. Longitudinal studies of West Nile virus infection in avians, Yucatan State, Mexico. Vector Borne Zoonotic Dis. 4:3-14.
11. Farfan-Ale, J. A., B. J. Blitvich, N. L. Marlenee, M. A. Loronio-Pino, F.Puerto-Manzano, J. E. Garcia-Rejon, E. P. Rosado-Paredes, L. F. Flores- Flores, A. Ortega-Salazar, J. Chavez-Medina, J. C. Cremieux-Grimaldi, F. Correa-Morales, G. Hernandez-Gaona, J. F. Mendez-Galvan, and B. J. Beaty. 2006. Antibodies to West Nile virus in asymptomatic mammals, birds, and reptiles in the Yucatan Peninsula of Mexico. Am. J. Trop. Med. Hyg.74:908-914.
12. Farfan-Ale, J. A., and M. A. Loroiio-Pino. 1991. Incidencia de infeccion por virus dengue en ninosde8a14anos de edad radicados en las areas urbana y rural del municipio de Merida, Yucatan. Bol. Med. Hosp. Infant Mex.48:780-784.
13. Gardner, I. A., and M. Greiner. 2006. Receiver-operating characteristic curves and likelihood ratios: improvements over traditional methods for the evaluation and application of veterinary clinical pathology tests. Vet. Clin. Pathol. 35:8-17.
14. Greiner, M., D. Pfeiffer, and R. D. Smith. 2000. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev. Vet. Med. 45:23-41.
15. Greiner, M., D. Sohr, and P. Gobel. 1995. A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of sero- diagnostic tests. J. Immunol. Methods 185:123-132.
16. Gubler, D. J. 2002. The global emergence/resurgence of arboviral diseases as public health problems. Arch. Med. Res. 33:330-342.
17. Hall, R. A., A. K. Broom, A. C. Hartnett, M. J. Howard, and J. S. Mackenzie. 1995. Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum. J. Virol. Methods 51:201-210.
18. Halstead, S. B., S. Rojanasuphot, and N. Sangkawibha. 1983. Original an- tigenic sin in dengue. Am. J. Trop. Med. Hyg. 32:154-156.
19. Hayes, E. B., and D. J. Gubler. 2006. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu. Rev.Med. 57:181-194.
20. Hayes, E. B., N. Komar, R. S. Nasci, S. P. Montgomery, D. R. O'Leary, and G. L. Campbell. 2005. Epidemiologyand transmissiondynamics ofWestNile virus disease. Emerg. Infect. Dis. 11:1167-1173.
21. Heck, F. C., J. D. Williams, and J. Pruett. 1980. Interpretation of spectro-photometric absorbance values to define results of enzyme-linked immu- nosorbent assays. J. Clin. Microbiol. 11:398-401.
22. Henchal, E. A., J. M. McCown, D. S. Burke, M. C. Seguin, and W. E. Brandt.1985. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am. J. Trop. Med. Hyg. 34:162-169.
23. Innis, B. L., A. Nisalak, S. Nimmannitya, S. Kusalerdchariya, V. Chongs- wasdi, S. Suntayakorn, P. Puttisri, and C. H. Hoke. 1989. Anenzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40:418-427.
24. Komar, N., and G. G. Clark. 2006. West Nile virus activity in Latin America and the Caribbean. Rev. Panam. Salud Publica 19:112-117.
25. Krieg, A. F., J. R. Beck, and M. B. Bongiovanni. 1988. The dot plot. A starting point for evaluating test performance. JAMA 260:3309-3312.
26. Kuno, G., D. J. Gubler, and A. Oliver. 1993. Use of 'original antigenic sin' theory to determine the serotypes of previous dengue infections. Trans. R.Soc. Trop. Med. Hyg. 87:103-105.
27. Lanciotti, R. S., C. H. Calisher, D. J. Gubler, G. J. Chang, and A. V.Vorndam. 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin.Microbiol. 30:545-551.
28. Loronio, M. A., J. A. Farfan, E. P. Rosado, A. I. Arjona, L. F. Flores, L. A.Manzano, and J. E. Zavala. 1989. Prevalencia de anticuerpos contra dengue en Yucatan, Mexico, 1985. Rev. Latinoam. Microbiol. 31:259-262.
29. Loronio-Pino, M. A., B. J. Blitvich, J. A. Farfan-Ale, F. I. Puerto, J. M.Blanco, N. L. Marlenee, E. P. Rosado-Paredes, J. E. Garcia-Rejon, D. J. Gubler, C. H. Calisher, and B. J. Beaty. 2003. Serologic evidence of West Nile virus infection in horses, Yucatan State, Mexico. Emerg. Infect. Dis.9:857-859.
30. Loronio-Pino, M. A. 2008. Characterization of epitope-blocking ELISA for differential diagnoses of secondary flavivirus infections. Ph.D. thesis. Colorado State University, Fort Collins.
31. Mackenzie, J. S., D. J. Gubler, and L. R. Petersen. 2004. Emerging flavivi- ruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10:S98-S109.
32. Martin, D. A., B. J. Biggerstaff, B. Allen, A. J. Johnson, R. S. Lanciotti, and J. T. Roehrig. 2002. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin. Diagn. Lab. Immunol. 9:544-549.
33. Oem, J. K., B. S. Chang, H. D. Joo, M. Y. Yang, G. J. Kim, J. Y. Park, Y. J. Ko, Y. J. Kim, J. H. Park, and Y. S. Joo. 2007. Development of an epitope- blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.J. Virol. Methods 142:174-181.
34. Pavri, K M., and S. N. Ghosh. 1969. Complement-fixation tests for simultaneous isolation and identification of Dengue viruses, using tissue cultures. Bull. W. H. O. 40:984-986.
35. Price, W. H., and J. S. Thind. 1971. Protection against WNV induced by a previous infection with dengue virus. Am. J. Epidemiol. 94:596-607.
36. Roehrig, J. T., R. A. Bolin, and R. G. Kelly. 1998. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246:317-328.
37. Sather, G. E., and W. M. Hammon. 1970. Protection against St. Louis encephalitis and West Nile arboviruses by previous dengue virus (types 1-4) infection. Proc. Soc. Exp. Biol. Med. 135:573-578.
38. Solomon, T. 2004. Flavivirus encephalitis. N. Engl. J. Med. 351:370-378.
39. Strickman, D., R. Sithiprasasna, P. Kittayapong, and B. L. Innis. 2000.Distribution of dengue and Japanese encephalitis among children in rural and suburban Thai villages. Am. J. Trop. Med. Hyg. 63:27-35.
40. Tesh, R. B., A. P. Travassos da Rosa, H. Guzman, T. P. Araujo, and S. Y. Xiao. 2002. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg. Infect. Dis. 8:245-251.
41. van Zyl, C., and F. M. Abrahamian. 2005. Update on emerging infections: news from the Centers for Disease Control and Prevention. Travel-associated dengue infections-United States, 2001-2004. Ann. Emerg. Med. 46:420-423.
42. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, and A. Nisalak. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181:2-9.